FDA Inspection 1287228 — Novacyl (Thailand) Ltd.

Novacyl (Thailand) Ltd. — FEI 3000287096

The FDA completed an inspection of Novacyl (Thailand) Ltd. on Apr 28, 2023 in Mueang Samut Prakan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 28, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mueang Samut Prakan (Thailand)

Additional details

Mutual Recognition Agreement (MRA)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.